CSTL Annual D&A
$12.33 M
+$1.79 M+16.95%
31 December 2023
Summary:
As of January 22, 2025, CSTL annual depreciation & amortization is $12.33 million, with the most recent change of +$1.79 million (+16.95%) on December 31, 2023. During the last 3 years, it has risen by +$11.86 million (+2512.29%). CSTL annual D&A is now at all-time high.CSTL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Quarterly D&A
$3.54 M
+$193.00 K+5.76%
30 September 2024
Summary:
As of January 22, 2025, CSTL quarterly depreciation & amortization is $3.54 million, with the most recent change of +$193.00 thousand (+5.76%) on September 30, 2024. Over the past year, it has increased by +$317.00 thousand (+9.83%). CSTL quarterly D&A is now at all-time high.CSTL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL TTM D&A
$13.45 M
+$367.00 K+2.80%
30 September 2024
Summary:
As of January 22, 2025, CSTL TTM depreciation & amortization is $13.45 million, with the most recent change of +$367.00 thousand (+2.80%) on September 30, 2024. Over the past year, it has increased by +$1.12 million (+9.11%). CSTL TTM D&A is now at all-time high.CSTL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.9% | +9.8% | +9.1% |
3 y3 years | +2512.3% | +9.8% | +9.1% |
5 y5 years | +3717.3% | +9.8% | +9.1% |
CSTL Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +261.9% | at high | +144.0% | at high | +294.9% |
5 y | 5-year | at high | +3344.1% | at high | +3791.2% | at high | +3657.8% |
alltime | all time | at high | +3867.2% | at high | +4354.1% | at high | >+9999.0% |
Castle Biosciences Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.54 M(+5.8%) | $13.45 M(+2.8%) |
June 2024 | - | $3.35 M(+0.2%) | $13.09 M(+2.4%) |
Mar 2024 | - | $3.34 M(+3.6%) | $12.78 M(+3.6%) |
Dec 2023 | $12.33 M(+16.9%) | $3.22 M(+1.6%) | $12.33 M(+3.2%) |
Sept 2023 | - | $3.17 M(+4.4%) | $11.95 M(+2.1%) |
June 2023 | - | $3.04 M(+5.1%) | $11.70 M(+3.7%) |
Mar 2023 | - | $2.89 M(+1.8%) | $11.28 M(+7.0%) |
Dec 2022 | $10.54 M(+209.5%) | $2.84 M(-2.8%) | $10.54 M(+15.2%) |
Sept 2022 | - | $2.92 M(+11.2%) | $9.15 M(+25.1%) |
June 2022 | - | $2.63 M(+22.2%) | $7.32 M(+37.4%) |
Mar 2022 | - | $2.15 M(+48.2%) | $5.33 M(+56.3%) |
Dec 2021 | $3.41 M | $1.45 M(+33.2%) | $3.41 M(+61.0%) |
Sept 2021 | - | $1.09 M(+71.8%) | $2.12 M(+84.6%) |
June 2021 | - | $634.00 K(+172.1%) | $1.15 M(+86.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $233.00 K(+45.6%) | $614.00 K(+30.1%) |
Dec 2020 | $472.00 K(+31.8%) | $160.00 K(+34.5%) | $472.00 K(+14.6%) |
Sept 2020 | - | $119.00 K(+16.7%) | $412.00 K(+7.3%) |
June 2020 | - | $102.00 K(+12.1%) | $384.00 K(+4.1%) |
Mar 2020 | - | $91.00 K(-9.0%) | $369.00 K(+3.1%) |
Dec 2019 | $358.00 K(+10.8%) | $100.00 K(+9.9%) | $358.00 K(+6.1%) |
Sept 2019 | - | $91.00 K(+4.6%) | $337.50 K(+2.3%) |
June 2019 | - | $87.00 K(+8.8%) | $329.80 K(+2.0%) |
Mar 2019 | - | $80.00 K(+0.6%) | $323.20 K(+0.1%) |
Dec 2018 | $323.00 K(+3.9%) | $79.50 K(-4.6%) | $323.00 K(+32.6%) |
Sept 2018 | - | $83.30 K(+3.6%) | $243.50 K(+52.0%) |
June 2018 | - | $80.40 K(+0.8%) | $160.20 K(+100.8%) |
Mar 2018 | - | $79.80 K | $79.80 K |
Dec 2017 | $310.80 K | - | - |
FAQ
- What is Castle Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Castle Biosciences?
- What is Castle Biosciences annual D&A year-on-year change?
- What is Castle Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Castle Biosciences?
- What is Castle Biosciences quarterly D&A year-on-year change?
- What is Castle Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Castle Biosciences?
- What is Castle Biosciences TTM D&A year-on-year change?
What is Castle Biosciences annual depreciation & amortization?
The current annual D&A of CSTL is $12.33 M
What is the all time high annual D&A for Castle Biosciences?
Castle Biosciences all-time high annual depreciation & amortization is $12.33 M
What is Castle Biosciences annual D&A year-on-year change?
Over the past year, CSTL annual depreciation & amortization has changed by +$1.79 M (+16.95%)
What is Castle Biosciences quarterly depreciation & amortization?
The current quarterly D&A of CSTL is $3.54 M
What is the all time high quarterly D&A for Castle Biosciences?
Castle Biosciences all-time high quarterly depreciation & amortization is $3.54 M
What is Castle Biosciences quarterly D&A year-on-year change?
Over the past year, CSTL quarterly depreciation & amortization has changed by +$317.00 K (+9.83%)
What is Castle Biosciences TTM depreciation & amortization?
The current TTM D&A of CSTL is $13.45 M
What is the all time high TTM D&A for Castle Biosciences?
Castle Biosciences all-time high TTM depreciation & amortization is $13.45 M
What is Castle Biosciences TTM D&A year-on-year change?
Over the past year, CSTL TTM depreciation & amortization has changed by +$1.12 M (+9.11%)